Genpact (G) Form 3: Director Thimaya Subaiya Reports No Holdings

Genpact Ltd. (G) Form 3 filing reports that Thimaya K. Subaiya, listed at C/O Genpact LLC, 521 Fifth Avenue, New York, NY, filed an initial Section 16 statement relating to an event on 07/31/2025.

Rhea-AI Filing Summary

Genpact Ltd. (G) Form 3 filing reports that Thimaya K. Subaiya, listed at C/O Genpact LLC, 521 Fifth Avenue, New York, NY, filed an initial Section 16 statement relating to an event on 07/31/2025. The filing identifies Subaiya as a Director and indicates no securities are beneficially owned at the time of this statement. The form was signed by an attorney-in-fact on 08/08/2025.

Positive

• Disclosure of director status for Thimaya K. Subaiya provides transparency
• Filing completed and signed by attorney-in-fact, indicating procedural compliance

Negative

• No securities beneficially owned at filing date, so there's no equity alignment disclosed

Insights

Corporate Governance Expert

TL;DR: Routine initial disclosure showing director appointment with no immediate equity ownership.

The Form 3 is a standard initial Section 16 filing. It names Thimaya K. Subaiya as a director of Genpact Ltd. and explicitly states that no securities are beneficially owned as of the reported event date. For governance review, this is a neutral disclosure: it documents the reporting obligation and provides transparency but contains no material equity changes, grants, or transactions that would affect share ownership or control.

Securities Compliance Analyst

TL;DR: Compliance filing completed; no derivative or non-derivative holdings disclosed.

The filing includes Table I and Table II headings but contains no entries, and references Exhibit 24.1 (Power of Attorney). The signature block shows the form was executed by an attorney-in-fact. From a compliance standpoint the document satisfies initial disclosure requirements by indicating relationship and ownership status; it does not present any reportable transactions or potential Section 16 reporting triggers beyond the initial statement.

FAQ

What does Genpact (G) Form 3 filed by Thimaya K. Subaiya report?

The Form 3 reports that Thimaya K. Subaiya is a Director of Genpact Ltd. and that no securities are beneficially owned as of the event date.

What is the event date reported on the Form 3 for Genpact (G)?

The event date reported on the Form 3 is 07/31/2025.

When was the Form 3 signed and by whom?

The signature block shows the form was signed by /s/ Thomas D. Scholtes, as Attorney-in-fact on 08/08/2025.

Does the Form 3 disclose any derivative or option holdings for Thimaya K. Subaiya?

No. Both Table I (non-derivative) and Table II (derivative) contain no entries and the filing states no securities are beneficially owned.

What address is listed for the reporting person on the Form 3?

The reporting person address is listed as C/O Genpact LLC, 521 Fifth Avenue, 14th Floor, New York, NY 10175.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 04:03 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Subaiya Thimaya K.

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/31/2025

3. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Thimaya K. Subaiya	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.